Orthofix Medical Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Orthofix Medical Inc. (OFIX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $31.62 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-05.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2024-03-05
- Orthofix Medical Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2023 was $31.62, a 17.09% decline from fiscal 2022.
- Orthofix Medical Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2022 was $38.14, a 16.16% decline from fiscal 2021.
- Orthofix Medical Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2021 was $45.49, a 12.70% decline from fiscal 2020.
- Orthofix Medical Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2020 was $52.11, a 4.98% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2023-12-31 | $31.62 10-K · filed 2024-03-05 |
| 2022-12-31 | $38.14 10-K · filed 2023-03-06 |
| 2021-12-31 | $45.49 10-K · filed 2022-02-25 |
| 2020-12-31 | $52.11 10-K · filed 2021-02-26 |
| 2019-12-31 | $54.84 10-K · filed 2020-02-24 |
| 2018-12-31 | $48.80 10-K · filed 2019-02-25 |
| 2017-12-31 | $42.50 10-K · filed 2018-02-26 |
| 2016-12-31 | $35.04 10-K · filed 2017-02-27 |
| 2015-12-31 | $38.92 10-K · filed 2016-02-29 |
| 2014-12-31 | $32.78 10-K · filed 2015-04-29 |
| 2013-12-31 | $36.33 10-K/A · filed 2015-03-31 |
| 2012-12-31 | $40.50 10-K/A · filed 2014-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |